AnalystsDebanjana ChatterjeeDebanjana Chatterjee's Stock Forecasts
AnalystsDebanjana Chatterjee
Sectors:
Industries:
Analyst Ranking
Top 34%
#1674 out of 4995 analysts
Average Return
+17.97%
Win Rate
89%8 out of 9
Risk vs Reward
Poor
Good
Debanjana Chatterjee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Sagimet Biosciences IncSGMT | +53.90% | $4.62 | $7.11 | 2025-01-27 - 2025-08-22 | Strong Buy |
Contineum Therapeutics IncCTNM | +39.22% | $7.14 | $9.94 | 2025-03-13 - 2025-08-22 | Strong Buy |
Tvardi Therapeutics IncTVRD | +33.44% | $21.02 | $28.05 | 2025-04-28 - 2025-08-22 | Strong Buy |
Theravance Biopharma IncTBPH | +31.23% | $10.60 | $13.91 | 2025-06-17 - 2025-08-22 | Strong Buy |
Sagimet Biosciences IncSGMT | +27.88% | $5.56 | $7.11 | 2025-06-06 - 2025-08-22 | Strong Buy |
Debanjana Chatterjee Analyst Color
Get additional color on Debanjana Chatterjee's coverage of popular stocks
Debanjana Chatterjee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Theravance Biopharma IncTBPH | 1 | Strong Buy | $24.00 | +72.54% | Initiates Coverage On | 2 months ago |
Sagimet Biosciences IncSGMT | 2 | Strong Buy | $27.00 | +279.75% | Maintains | 3 months ago |
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $39.00 | +39.04% | Initiates Coverage On | 4 months ago |
Kalvista Pharmaceuticals IncKALV | 2 | Strong Buy | $30.00 | +123.71% | Maintains | 5 months ago |
Contineum Therapeutics IncCTNM | 1 | Strong Buy | $23.00 | +131.39% | Initiates Coverage On | 5 months ago |
Pharvaris NvPHVS | 1 | Strong Buy | $46.00 | +98.96% | Initiates Coverage On | a year ago |
Intellia Therapeutics IncNTLA | 1 | Strong Buy | $41.00 | +289.73% | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.